{
    "2021-04-27": [
        [
            {
                "time": "2021-04-27",
                "original_text": "云南白药一季度净利润同比下降40%的背后是因为炒股“失利”！盈利能力下降",
                "features": {
                    "keywords": [
                        "云南白药",
                        "一季度",
                        "净利润",
                        "同比下降",
                        "炒股",
                        "失利",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-04-27",
                "original_text": "晚间公告丨4月27日这些公告有看头",
                "features": {
                    "keywords": [
                        "晚间公告",
                        "4月27日"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-04-27",
                "original_text": "云南白药一季度增收不增利 基本每股收益下降40% 盈利能力下降",
                "features": {
                    "keywords": [
                        "云南白药",
                        "一季度",
                        "增收不增利",
                        "每股收益",
                        "下降40%",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-04-27",
                "original_text": "云南白药(000538.SZ)第一季度归母净利润同比下降40.48%至7.63亿元 盈利能力下降",
                "features": {
                    "keywords": [
                        "云南白药",
                        "第一季度",
                        "归母净利润",
                        "同比下降",
                        "40.48%",
                        "7.63亿元",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-04-27",
                "original_text": "云南白药：2021年第一季度净利润约7.63亿元，同比下降40.48% 盈利能力下降",
                "features": {
                    "keywords": [
                        "云南白药",
                        "2021年第一季度",
                        "净利润",
                        "7.63亿元",
                        "同比下降",
                        "40.48%",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-04-27",
                "original_text": "云南白药(000538.SZ)一季度扣非净利润升29.42%至13.65亿元",
                "features": {
                    "keywords": [
                        "云南白药",
                        "一季度",
                        "扣非净利润",
                        "升29.42%",
                        "13.65亿元"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-27",
                "original_text": "云南白药：一季度净利润7.63亿元，同比下降40.48% 盈利能力下降",
                "features": {
                    "keywords": [
                        "云南白药",
                        "一季度",
                        "净利润",
                        "7.63亿元",
                        "同比下降",
                        "40.48%",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-07-30",
                "original_text": "电鳗快报|云南白药拟控股港股公司布局工业大麻全产业链 7月30日前“定乾坤”",
                "features": {
                    "keywords": [
                        "云南白药",
                        "控股",
                        "港股公司",
                        "工业大麻",
                        "全产业链",
                        "7月30日"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "工业大麻"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}